128 related articles for article (PubMed ID: 642709)
1. Hypotensive response to debrisoquine and hydroxylation phenotype.
Idle JR; Mahgoub A; Lancaster R; Smith RL
Life Sci; 1978 Mar; 22(11):979-83. PubMed ID: 642709
[No Abstract] [Full Text] [Related]
2. Polymorphic hydroxylation of debrisoquine.
Tucker GT; Silas JH; Iyun AO; Lennard MS; Smith AJ
Lancet; 1977 Oct; 2(8040):718. PubMed ID: 71525
[No Abstract] [Full Text] [Related]
3. Polymorphic 4-hydroxylation of debrisoquine in chronic discoid psoriasis.
Chapman PH; Rawlins MD; Shuster S; Idle JR; Ritchie JC; Smith RL
Eur J Clin Pharmacol; 1981; 21(3):257-8. PubMed ID: 6895622
[No Abstract] [Full Text] [Related]
4. The disposition of debrisoquine in hypertensive patients.
Silas JH; Lennard MS; Tucker GT; Smith AJ; Malcolm SL; Marten TR
Br J Clin Pharmacol; 1978 Jan; 5(1):27-34. PubMed ID: 619932
[No Abstract] [Full Text] [Related]
5. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants.
Bertilsson L; Aberg-Wistedt A; Gustafsson LL; Nordin C
Ther Drug Monit; 1985; 7(4):478-80. PubMed ID: 4082245
[No Abstract] [Full Text] [Related]
6. Diazepam treatment does not influence the debrisoquine or mephenytoin hydroxylation phenotyping tests.
Spina E; Buemi AL; Sanz E; Bertilsson L
Ther Drug Monit; 1989 Nov; 11(6):721-3. PubMed ID: 2595755
[TBL] [Abstract][Full Text] [Related]
7. Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications.
Bertilsson L; Mellström B; Sjökvist F; Mårtenson B; Asberg M
Lancet; 1981 Mar; 1(8219):560-1. PubMed ID: 6111662
[No Abstract] [Full Text] [Related]
8. Debrisoquine hydroxylation phenotypes in healthy volunteers.
Llerena A; Cobaleda J; Benítez J
Lancet; 1989 Jun; 1(8651):1398. PubMed ID: 2567421
[No Abstract] [Full Text] [Related]
9. Polymorphism of debrisoquine hydroxylation among Finns and Lapps.
Arvela P; Kirjarinta M; Kirjarinta M; Kärki N; Pelkonen O
Br J Clin Pharmacol; 1988 Nov; 26(5):601-3. PubMed ID: 3207564
[TBL] [Abstract][Full Text] [Related]
10. Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism.
Alván G; Grind M; Graffner C; Sjöqvist F
Clin Pharmacol Ther; 1984 Oct; 36(4):515-9. PubMed ID: 6478737
[TBL] [Abstract][Full Text] [Related]
11. Debrisoquine hydroxylation phenotyping: do we expect too much?
Mitchell SC; Haley CS
Lancet; 1990 Sep; 336(8716):694. PubMed ID: 1975883
[No Abstract] [Full Text] [Related]
12. Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese.
Yue QY; Bertilsson L; Dahl-Puustinen ML; Säwe J; Sjöqvist F; Johansson I; Ingelman-Sundberg M
Lancet; 1989 Oct; 2(8667):870. PubMed ID: 2571799
[No Abstract] [Full Text] [Related]
13. Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings].
Andoh B; Idle JR; Mahgoub A; Sloan TP; Smith RL; Woolhouse N
Br J Pharmacol; 1979 Jul; 66(3):431P. PubMed ID: 526720
[No Abstract] [Full Text] [Related]
14. Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism.
Küpfer A; Schmid B; Preisig R; Pfaff G
Lancet; 1984 Sep; 2(8401):517-8. PubMed ID: 6147572
[No Abstract] [Full Text] [Related]
15. Diurnal effects on debrisoquine hydroxylation phenotyping.
Lee EJ
Eur J Clin Pharmacol; 1988; 35(4):441-2. PubMed ID: 3197754
[TBL] [Abstract][Full Text] [Related]
16. Why hypertensive patients vary in their response to oral debrisoquine.
Silas JH; Lennard MS; Tucker GT; Smith AJ; Malcolm SL; Marten TR
Br Med J; 1977 Feb; 1(6058):422-5. PubMed ID: 837136
[TBL] [Abstract][Full Text] [Related]
17. Discovery of altered pharmacokinetics of CGP 15 210 G in poor hydroxylators of debrisoquine during early drug development.
Gleiter CH; Aichele G; Nilsson E; Hengen N; Antonin KH; Bieck PR
Br J Clin Pharmacol; 1985 Jul; 20(1):81-4. PubMed ID: 4027140
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio.
Nordin C; Siwers B; Benitez J; Bertilsson L
Br J Clin Pharmacol; 1985 Jun; 19(6):832-5. PubMed ID: 4027124
[TBL] [Abstract][Full Text] [Related]
19. A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians.
Mahgoub A; Idle JR; Smith RL
Xenobiotica; 1979 Jan; 9(1):51-6. PubMed ID: 760321
[TBL] [Abstract][Full Text] [Related]
20. Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in man.
Bertilsson L; Eichelbaum M; Mellström B; Säwe J; Schulz HU; Sjöqvist F
Life Sci; 1980 Nov; 27(18):1673-7. PubMed ID: 7442467
[No Abstract] [Full Text] [Related]
[Next] [New Search]
